Dr. Julien Meissonnier, Pharmaceutical Softgel Europe, Catalent looks at lipid-based formulations to increase the bioavailability of poorly soluble drugs.
The FDA has approved the Raplixa fibrin sealant and the Raplixa spray device to provide adjunctive haemostasis for mild to moderate bleeding in adults in surgery.
The advances made in the pharma sector are well documented. Whether we are looking at drug development for stopping smoking or the latest cancer fighting formulations, the range of groundbreaking pharmaceutical products continues to increase.
Colin White, general manager, Penn Pharma, A PCI company, PCI talks to EPM about the company’s recent expansions and its core business strengths going forward
Today’s pharma industry is suffering a crisis of trust, say Bart Sayle and Nick Hawker, The Breakthrough Group. They discuss creating a culture of trust and breakthrough in the industry.
